Ryan C. Larrenaga
About Ryan C. Larrenaga
Ryan C. Larrenaga (year of birth: 1970) serves as Senior Vice President (since 2017), Chief Legal Officer (since 2017), and Secretary (since 2015) of Columbia Seligman Premium Technology Growth Fund (STK). He is Vice President and Chief Counsel at Ameriprise Financial, Inc. since August 2018, previously Vice President and Group Counsel from August 2011 to August 2018; he has been an officer of the Columbia Funds and affiliated funds since 2005 . As Chief Legal Officer/Secretary, he executes Rule 17g‑1 fidelity bond filings on behalf of STK and affiliated funds, evidencing a core compliance and governance remit .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Ameriprise Financial, Inc. | Vice President & Chief Counsel | Aug 2018–present | Senior legal leadership supporting Columbia/Threadneedle fund complex |
| Ameriprise Financial, Inc. | Vice President & Group Counsel | Aug 2011–Aug 2018 | Legal counsel for asset management operations |
| Columbia Funds & affiliated funds | Officer; Chief Legal Officer of Columbia Funds | Officer since 2005; CLO since 2017 | Executed fidelity bond filings under Rule 17g‑1 for STK and related funds |
External Roles
No external board roles or public company directorships are disclosed in STK’s proxy biography for Larrenaga; the biography lists only his roles within Ameriprise/Columbia .
Fixed Compensation
Officers who are employees of the Manager (Ameriprise/Columbia) do not receive compensation from the Fund (STK), other than the Fund’s CCO whose compensation is partially paid by the funds. The proxy does not disclose Ryan Larrenaga’s base salary, bonus, or employer-paid compensation (which would be at Ameriprise) .
| Component | Fund-paid amount | Notes |
|---|---|---|
| Base salary | $0 | “No compensation is paid by the Fund… to Directors or officers… who are employees or officers of the Manager or its affiliates,” except the CCO portion |
| Target/Actual bonus | $0 | Not paid by Fund; employer-paid compensation not disclosed in Fund proxy |
| Perquisites/Pension/Deferred comp | Not disclosed | Not disclosed for officers; director deferred comp program described separately (not applicable to Larrenaga) |
Performance Compensation
No performance‑based compensation from the Fund is disclosed for officers who are employees of the Manager; STK does not grant stock options/RSUs to such officers, and no Fund‑level incentives for Larrenaga are reported .
Not applicable at the Fund level for Manager-employed officers; no vesting schedules, option awards, or PSU metrics tied to Fund pay are disclosed for Larrenaga .
Equity Ownership & Alignment
| Metric | As of | Value | Notes |
|---|---|---|---|
| Directors & officers of the Fund (as a group) beneficial ownership | Dec 31, 2024 | Less than 1% of Common Stock | Group-level disclosure only; individual officer holdings (including Larrenaga) not itemized in proxy |
- No disclosure of shares pledged as collateral, hedging restrictions for officers, or ownership guideline compliance is provided in STK’s proxy for officers; only director ownership ranges are shown and a group-level <1% statement for directors/officers .
Employment Terms
- Officers are elected by the Board and “serve at the pleasure of the Board,” indicating at‑will service without a term of years disclosed .
- The proxy does not disclose employment contracts, severance multiples, change‑of‑control triggers, non‑compete/non‑solicit terms, garden leave, or consulting arrangements for officers employed by the Manager .
Investment Implications
- Alignment signals at the Fund level are limited: STK does not pay compensation to Manager‑employed officers and does not grant Fund equity/option awards to them, reducing Fund‑level pay‑for‑performance and vesting‑driven selling pressure for Larrenaga .
- Insider trading signal scarcity: with no Fund equity awards and group‑level beneficial ownership under 1%, there is little in the proxy to indicate officer‑driven insider selling risk tied to vesting or option exercises for Larrenaga .
- Retention risk appears primarily tied to Ameriprise employment (outside Fund disclosures); within STK governance, Larrenaga’s at‑pleasure appointment underscores Board control but provides no severance/change‑of‑control economics to evaluate at the Fund level .
- Role significance is governance/compliance rather than investment performance: his execution of Rule 17g‑1 filings and legal leadership points to strong process oversight, with limited direct linkage to Fund TSR or financial metrics disclosed for his role .